Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children

被引:42
作者
Millar, EV
O'Brien, KL
Levine, OS
Kvamme, S
Reid, R
Santosham, M
机构
[1] Johns Hopkins Univ, Ctr Amer Indian & Alaskan Native Hlth, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA
[2] NIAID, Resp Dis Branch, NIH, Bethesda, MD 20892 USA
[3] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA
关键词
D O I
10.2105/AJPH.90.10.1550
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This report describes the epidemiology of Haemophilus influenzae type b (Hib) invasive disease and oropharyngeal among Navajo and White: Mountain Apache children younger than 7 years in an era of wide-spread immunization. Methods. We conducted active surveillance for-invasive H influenzae disease from 1992 to 1999 and an oropharyngeal carriage study from 1997 to 1999. The predominant vaccine used was PedvaxHib. Results. The average annual incidence of invasive Hib disease among children younger:than 24 months was 22 cases per 100 000. Of 381 children younger than 7 years, only 1 (0.3%; 95% confidence interval = 0.0%, 1.3%) was colonized with Hib; 370 (97%) had received 2 or more doses of Hib conjugate vaccine. Conclusions Among Navajo and White Mountain Apache children, Hib conjugate vaccines have led to a sustained reduction in invasive Hib disease and a reduction in oropharyngeal Hib carriage. The disease incidence among children younger than 24 months remains 20 times higher than in the general US population. Hib elimination will require additional characterization of colonization and disease in these high-risk populations.
引用
收藏
页码:1550 / 1554
页数:5
相关论文
共 19 条
[1]   Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H-influenzae type b among Gambian children [J].
Adegbola, RA ;
Mulholland, EK ;
Secka, O ;
Jaffar, S ;
Greenwood, BM .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1758-1761
[2]   THE IMPACT OF CONJUGATE VACCINE ON CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
BARBOUR, ML ;
MAYONWHITE, RT ;
COLES, C ;
CROOK, DWM ;
MOXON, ER .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :93-98
[3]   Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease [J].
Bisgard, KM ;
Kao, A ;
Leake, J ;
Strebel, PM ;
Perkins, BA ;
Wharton, M .
EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :229-237
[4]  
Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P993
[5]  
COULEHAN JL, 1984, PUBLIC HEALTH REP, V99, P404
[6]   Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with Hib polyribosylribitol phosphate polysaccharide-tetanus toroid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine [J].
Forleo-Neto, E ;
de Oliveira, CF ;
Maluf, EMCP ;
Bataglin, C ;
Araujo, JMR ;
Kunz, LF ;
Pustai, AK ;
Vieria, VSD ;
Zanella, RC ;
Brandileone, MC ;
Mimica, LMJ ;
Mimica, IM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :1153-1158
[7]   Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska [J].
Galil, K ;
Singleton, R ;
Levine, OS ;
Fitzgerald, MA ;
Bulkow, L ;
Getty, M ;
Perkins, BA ;
Parkinson, A .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :101-106
[8]   POSTLICENSURE EFFECTIVENESS OF THE HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE NEISSERIA-MENINGITIDIS OUTER-MEMBRANE PROTEIN COMPLEX CONJUGATE VACCINE AMONG NAVAJO CHILDREN [J].
HARRISON, LH ;
TAJKOWSKI, C ;
CROLL, J ;
REID, R ;
HU, D ;
BRENNEMAN, G ;
WEATHERHOLTZ, RC ;
SANTOSHAM, M .
JOURNAL OF PEDIATRICS, 1994, 125 (04) :571-576
[9]  
Levine O, 1998, Bull World Health Organ, V76 Suppl 2, P131
[10]   HEMOPHILUS-INFLUENZAE DISEASE IN THE WHITE MOUNTAIN APACHES - MOLECULAR EPIDEMIOLOGY OF A HIGH-RISK POPULATION [J].
LOSONSKY, GA ;
SANTOSHAM, M ;
SEHGAL, VM ;
ZWAHLEN, A ;
MOXON, ER .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1984, 3 (06) :539-547